Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
Journal of Medicinal Chemistry
|
July 11, 2003
First dual aromatase-steroid sulfatase inhibitors
L W Lawrence Woo, Oliver B Sutcliffe, Christian Bubert, et al.
Anticancer Research
|
September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression
Chloe Stengel, Simon P Newman, Mathew P Leese, et al.
Journal of Dental Education
|
November 18, 2009
Developing dental faculty for the future: ADEA/AAL Institute for Teaching and Learning, 2006-09
N Karl Haden, William D Hendricson, John W Killip, et al.
Breast Cancer Research and Treatment
|
October 25, 2007
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique
Paul A Foster, Yaik T Ho, Simon P Newman, et al.
Chemmedchem
|
September 26, 2008
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities
Christian Bubert, L W Lawrence Woo, Oliver B Sutcliffe, et al.
Biochemical and Biophysical Research Communications
|
March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor
Julie E Reed, L W Lawrence Woo, James J Robinson, et al.
The Biochemical Journal
|
September 30, 2004
Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent
Matthew D Lloyd, Richard L Pederick, Ramanathan Natesh, et al.
Journal of Medicinal Chemistry
|
April 15, 2005
Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
Harshani R Lawrence, Nigel Vicker, Gillian M Allan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy
Paul A Foster, Simon P Newman, Surinder K Chander, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
Journal of Medicinal Chemistry
|
July 11, 2003
First dual aromatase-steroid sulfatase inhibitors
L W Lawrence Woo, Oliver B Sutcliffe, Christian Bubert, et al.
Anticancer Research
|
September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression
Chloe Stengel, Simon P Newman, Mathew P Leese, et al.
Journal of Dental Education
|
November 18, 2009
Developing dental faculty for the future: ADEA/AAL Institute for Teaching and Learning, 2006-09
N Karl Haden, William D Hendricson, John W Killip, et al.
Breast Cancer Research and Treatment
|
October 25, 2007
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique
Paul A Foster, Yaik T Ho, Simon P Newman, et al.
Chemmedchem
|
September 26, 2008
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities
Christian Bubert, L W Lawrence Woo, Oliver B Sutcliffe, et al.
Biochemical and Biophysical Research Communications
|
March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor
Julie E Reed, L W Lawrence Woo, James J Robinson, et al.
The Biochemical Journal
|
September 30, 2004
Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent
Matthew D Lloyd, Richard L Pederick, Ramanathan Natesh, et al.
Journal of Medicinal Chemistry
|
April 15, 2005
Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
Harshani R Lawrence, Nigel Vicker, Gillian M Allan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy
Paul A Foster, Simon P Newman, Surinder K Chander, et al.
Page
of 8